市場調查報告書
商品編碼
1615921
RFID 在藥品市場機會、成長動力、產業趨勢分析與預測 2024 - 2032 年RFID in Pharmaceuticals Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032 |
2023 年,全球 RFID 藥品市場資料達到 38 億美元,2024 年至 2032 年複合年成長率將達到 7.7%。 。這些標籤可以儲存有關藥品的詳細資訊,包括批次號、有效期和製造詳細資訊,確保全面的可追溯性。將 RFID 與區塊鏈技術結合對於確保藥品供應鏈的安全性越來越受到關注。區塊鏈提供了一個不可變的分類賬,記錄 RFID 標籤產品的每筆交易和移動,確保透明度並防止篡改或詐欺。
這種組合增強了追蹤資訊的可信度,有助於驗證藥品的真實性。 RFID 標籤產品領域佔據市場主導地位,到 2023 年價值將達到 17 億美元。每個標籤都可以儲存唯一識別碼和附加資料,確保可以追蹤產品從製造到銷售點的整個過程。這種可追溯性對於防止假藥和確保產品真實性至關重要,這是製藥業的關鍵問題。
RFID標籤用途廣泛,可應用於各種類型的藥品,包括單一藥品包裝、托盤和醫療設備。這種多功能性允許對多個層級的庫存進行全面追蹤和管理,這對於製藥公司和醫療保健提供者來說是一個顯著的優勢。預計到2032 年,晶片式RFID 市場將佔據市場主導地位。 。這些標籤支援加密和身份驗證協議,提供卓越的防偽保護,這對於確保藥品的完整性至關重要。
市場範圍 | |
---|---|
開始年份 | 2023年 |
預測年份 | 2024-2032 |
起始值 | 38億美元 |
預測值 | 73 億美元 |
複合年成長率 | 7.7% |
這些特徵有助於細分市場的成長。 RFID技術透過提供藥品位置和狀態的即時可見性來提高醫療保健供應鏈管理的效率和準確性,從而減少錯誤並改善庫存管理。這反過來又增加了他們的市場需求。 2023 年北美 RFID 在藥品市場的規模將超過 15 億美元,預計在分析時間內複合年成長率為 6.6%。
北美對醫療保健基礎設施的大量投資有助於擴大 RFID 系統在藥品領域的應用。對改善醫療服務和病人安全的關注推動了先進追蹤和追蹤技術的採用。由於製藥業的高水準創新和基礎設施準備就緒,北美在採用 RFID 等先進技術方面處於領先地位,推動了該地區的市場成長。
The Global RFID In Pharmaceuticals Market reached a valuation of USD 3.8 billion in 2023 and will expand at a CAGR of 7.7% from 2024 to 2032. Modern RFID tags now offer enhanced data storage, longer read ranges, and greater durability. These tags can store detailed information about pharmaceutical products, including batch numbers, expiration dates, and manufacturing details, ensuring comprehensive traceability. Integrating RFID with blockchain technology is gaining traction to secure the pharmaceutical supply chain. Blockchain provides an immutable ledger that records every transaction and movement of RFID-tagged products, ensuring transparency and preventing tampering or fraud.
This combination enhances the credibility of tracking information and helps verify the authenticity of pharmaceuticals. The RFID tags product segment dominated the market, valued at USD 1.7 billion in 2023. RFID tags provide detailed and accurate information about pharmaceutical products throughout the supply chain. Each tag can store a unique identifier and additional data, ensuring that products can be tracked from manufacturing to the point of sale. This traceability is essential for preventing counterfeit drugs and ensuring product authenticity, a critical concern in the pharmaceutical industry.
RFID tags are versatile and can be applied to various types of pharmaceutical products, including individual drug packages, pallets, and medical equipment. This versatility allows for comprehensive tracking and management of inventory at multiple levels, which is a significant advantage for pharmaceutical companies and healthcare providers. The chipped RFID segment is anticipated to dominate the market by 2032. Chipped RFID tags can store and process detailed information such as product IDs, batch numbers, and expiration dates, which is essential for traceability and regulatory compliance in the pharmaceutical industry. The tags support encryption and authentication protocols, offering superior protection against counterfeiting, which is crucial for ensuring the integrity of pharmaceutical products.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $3.8 Billion |
Forecast Value | $7.3 Billion |
CAGR | 7.7% |
These features contribute to segmental growth. RFID technology enhances the efficiency and accuracy of healthcare supply chain management by providing real-time visibility into the location and status of pharmaceutical products, thereby reducing errors and improving inventory management. This, in turn, increases their demand in the market. North America RFID in pharmaceuticals market size in 2023 was over USD 1.5 billion and is predicted to grow at a CAGR of 6.6% over the analysis timeframe.
Significant investments in healthcare infrastructure in North America contribute to the expansion of RFID systems in pharmaceuticals. The focus on improving healthcare delivery and patient safety drives the adoption of advanced tracking and tracing technologies. North America leads in the adoption of advanced technologies, including RFID, due to a high level of innovation and infrastructure readiness in the pharmaceutical sector, driving market growth in the region.